{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:43:25Z","timestamp":1791301405705,"version":"4.1.0"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:p>Most chromosomal abnormalities associated with breakage at 11q23 in acute leukaemia involve the <jats:italic>MLL<\/jats:italic> gene, and the presence of this breakage strongly predicts a poor clinical outcome. We assessed the possibility of differentiation\u2010inducing therapy for acute leukaemias with chromosomal translocations involving 11q23. Among the cell lines with <jats:italic>MLL<\/jats:italic> translocations that we examined, KOCL48 and KOPN\u20101 cells were induced to differentiate into granulocytes by all\u2010<jats:italic>trans<\/jats:italic> retinoic acid (ATRA) or into monocytes by 1\u03b1,25\u2010dihydroxyvitamin D<jats:sub>3<\/jats:sub> (VD3). These cells expressed <jats:italic>p16<\/jats:italic> mRNA before treatment with 5\u2010aza\u20102\u2032\u2010deoxycytidine (5\u2010AZA), an inhibitor of DNA methylation. On the other hand, differentiation was not induced in SN\u20101, KOCL33, KOCL51 or KOCL44 cells by ATRA or VD3, and these cells did not express mRNA of this gene. However, these cells were effectively induced to differentiate by ATRA or VD3 in the presence of 5\u2010AZA, and concomitantly exhibited <jats:italic>p16<\/jats:italic> gene expression, suggesting an association between DNA demethylation and restoration of sensitivity to differentiation\u2010inducing activity of ATRA or VD3 in leukaemia cells with <jats:italic>MLL<\/jats:italic> abnormalities. Based on these findings, combined treatment with ATRA or VD3 plus 5\u2010AZA may be clinically useful in therapy for acute leukaemia with <jats:italic>MLL<\/jats:italic> abnormalities.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02523.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:31:08Z","timestamp":1047364268000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Sensitization by 5\u2010aza\u20102\u2032\u2010deoxycytidine of leukaemia cells with <i>MLL<\/i> abnormalities to induction of differentiation by all\u2010<i>trans<\/i> retinoic acid and 1\u03b1,25\u2010dihydroxyvitamin D<sub>3<\/sub>"],"prefix":"10.1111","volume":"112","author":[{"given":"Nozomi","family":"Niitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.5.2936"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199810000-00001"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)68144-5","article-title":"Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5\u2010azacytidine and 5\u2010aza\u20102\u2032\u2010deoxycytidine","volume":"257","author":"Creusot F.","year":"1982","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01439.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199206000-00012"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90603-A"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880215)61:4<712::AID-CNCR2820610414>3.0.CO;2-6"},{"key":"e_1_2_6_9_1","first-page":"1139","article-title":"SN\u20101, a novel leukemic cell line with t(11;16)(q23;p13): Myeloid characteristics and resistance to retinoid and vitamin D3","volume":"60","author":"Hayashi Y.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_6_10_1","volume-title":"Cancer Cytogenetics: Chromosomal and Molecular Aberrations of Tumor Cells","author":"Heim S.","year":"1995"},{"key":"e_1_2_6_11_1","first-page":"722","article-title":"Hypermethylation\u2010associated inactivation indicates a tumor suppresser role for p15INK4B","volume":"56","author":"Herman J.G.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(80)90813-X"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.567.567"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1182\/blood.V81.12.3197.3197","article-title":"HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities","volume":"81","author":"Hunger S.P.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(92)90113-L"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1993.tb00172.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201428"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1909.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400796"},{"key":"e_1_2_6_20_1","first-page":"2235","article-title":"Deletions of the p16 gene in pediatric leukemia and corresponding cell lines","volume":"12","author":"Kees U.R.","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1182\/blood.V87.8.3384.bloodjournal8783384","article-title":"Enhancement of activity of 1alpha, 25\u2010dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha\u2010tocopherol ester of all\u2010trans retinoic acid","volume":"85","author":"Makishima M.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0795-686"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2017.bloodjournal8582017"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(85)90123-7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(85)90052-X"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401016"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood.V90.11.4532","article-title":"Adult patients with de novo acute myeloid leukemia and t (9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study","volume":"90","author":"Mrozek K.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_28_1","first-page":"2138","article-title":"Clinical pharmacology of oral all\u2010trans retinoic acid in patients with acute promyelocytic leukemia","volume":"15","author":"Muindi J.R.","year":"1992","journal-title":"Cancer Research"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401437"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7250"},{"key":"e_1_2_6_31_1","first-page":"319","article-title":"AML1a, but not AML1b, inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells","volume":"8","author":"Niitsu N.","year":"1997","journal-title":"Cell Growth and Differentiation"},{"key":"e_1_2_6_32_1","first-page":"36","article-title":"Pilot study of 5\u2010aza\u20102\u2032\u2010deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary results","volume":"7","author":"Petti M.C.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.4.922.922"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401725"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.258"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(81)90116-8"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genet.32.1.495"},{"key":"e_1_2_6_38_1","first-page":"74","article-title":"11q23 rearrangements in acute leukemia","volume":"10","author":"Rubnitz J.E.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.11.4804.bloodjournal87114804"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.191"},{"key":"e_1_2_6_41_1","first-page":"S28","article-title":"Decitabine (5\u2010Aza\u20102\u2032\u2010deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations","volume":"11","author":"Schwartsmann G.","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401011"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2563"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202540"},{"key":"e_1_2_6_45_1","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood.V82.12.3705.3705","article-title":"Rearrangements of the MLL gene in therapy\u2010related acute myeloid leukemia in patients previously treated with agents targeting DNA\u2010topoisomerase II","volume":"82","author":"Super H.J.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401014"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.12110"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90602-9"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.4106"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690165"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105163242002"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400526"},{"key":"e_1_2_6_53_1","first-page":"S24","article-title":"A randomized phase II study on the effects of 5\u2010Aza\u20102\u2032\u2010deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Co\u2010operative Group phase II study (06893)","volume":"11","author":"Willemze R.","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_6_54_1","first-page":"168","article-title":"Transcriptional silencing of the p16 gene in human myeloma\u2010derived cell lines by hypermethylation","volume":"103","author":"Wong I.H.","year":"1998","journal-title":"British Journal of Haematology"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.5.1778"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.10.2912.2912"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/382319a0"},{"key":"e_1_2_6_58_1","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood.V88.9.3555.bloodjournal8893555","article-title":"Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia","volume":"88","author":"Yokoyama A.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.23.10735"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02523.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02523.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02523.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T22:10:12Z","timestamp":1697580612000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02523.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02523.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02523.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}